August 15, 2022 6:11 a.m. EDT
(24/7 MARKET NEWS) Plus Therapeutics (NASDAQ: PSTV) is trading higher in this morning’s premarket, at $0.815, up $0.287 (+54.30%), on 3.39 million premarket shares traded.
This morning’s price action follows the clinical-stage pharmaceutical company’s positive data report from ongoing ReSPECT(TM) clinical trials at the annual CNS Clinical Trials and Brain Metastases conference, on Saturday. Plus Therapeutics has taken out its early June highs and could mean that it wants to challenge the dollar range, which it hasn’t seen since early April.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.
Please go to https://www.247marketnews.com/terms-disclaimer/ for further information.
